Figure 2
From: Alterations of global histone H4K20 methylation during prostate carcinogenesis
The columns show the distribution of the different global H4K20 methylation levels in non-malignant prostate tissue (n = 23), localized prostate cancer (PCA; n = 113), metastatic hormone-naïve prostate cancer (mPCA; n = 30) and castration-resistant prostate cancer (CRPC; n = 34). H4K20 methylation levels were categorized into weak (≤ 4), moderate (5-8) and strong (≥ 9).